Stocks and Investing Stocks and Investing
Thu, February 13, 2020
Wed, February 12, 2020
Tue, February 11, 2020
Mon, February 10, 2020
Sun, February 9, 2020
Fri, February 7, 2020

David Lebovitz Maintained (ALNY) at Buy with Decreased Target to $148 on, Feb 7th, 2020


Published on 2024-10-26 21:35:00 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $150 to $148 on, Feb 7th, 2020.

David has made no other calls on ALNY in the last 4 months.



There are 4 other peers that have a rating on ALNY. Out of the 4 peers that are also analyzing ALNY, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $190 on, Thursday, December 19th, 2019
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $176 on, Wednesday, December 18th, 2019
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $143 on, Monday, November 25th, 2019
  • Leland Gershell of "Oppenheimer" Initiated at Buy and Held Target at $128 on, Wednesday, November 20th, 2019